NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.

Natural killer (NK) cells play a critical role in virus control. However, it has remained largely unclear whether NK cell mobilization in SARS-CoV-2 infections is beneficial or pathologic. To address this deficit, we employed a validated experimental NK cell depletion non-human primate (NHP) model w...

Full description

Saved in:
Bibliographic Details
Main Authors: Harikrishnan Balachandran, Kyle Kroll, Karen Terry, Cordelia Manickam, Rhianna Jones, Griffin Woolley, Tammy Hayes, Amanda J Martinot, Ankur Sharma, Mark Lewis, Stephanie Jost, R Keith Reeves
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-08-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.1012439
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595684040114176
author Harikrishnan Balachandran
Kyle Kroll
Karen Terry
Cordelia Manickam
Rhianna Jones
Griffin Woolley
Tammy Hayes
Amanda J Martinot
Ankur Sharma
Mark Lewis
Stephanie Jost
R Keith Reeves
author_facet Harikrishnan Balachandran
Kyle Kroll
Karen Terry
Cordelia Manickam
Rhianna Jones
Griffin Woolley
Tammy Hayes
Amanda J Martinot
Ankur Sharma
Mark Lewis
Stephanie Jost
R Keith Reeves
author_sort Harikrishnan Balachandran
collection DOAJ
description Natural killer (NK) cells play a critical role in virus control. However, it has remained largely unclear whether NK cell mobilization in SARS-CoV-2 infections is beneficial or pathologic. To address this deficit, we employed a validated experimental NK cell depletion non-human primate (NHP) model with SARS-CoV-2 Delta variant B.1.617.2 challenge. Viral loads (VL), NK cell numbers, activation, proliferation, and functional measures were evaluated in blood and tissues. In non-depleted (control) animals, infection rapidly induced NK cell expansion, activation, and increased tissue trafficking associated with VL. Strikingly, we report that experimental NK cell depletion leads to higher VL, longer duration of viral shedding, significantly increased levels of pro-inflammatory cytokines in the lungs, and overt lung damage. Overall, we find the first significant and conclusive evidence for NK cell-mediated control of SARS-CoV-2 virus replication and disease pathology. These data indicate that adjunct therapies for infection could largely benefit from NK cell-targeted approaches.
format Article
id doaj-art-6060b7066f3a4926857118d4855db1c9
institution Kabale University
issn 1553-7366
1553-7374
language English
publishDate 2024-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-6060b7066f3a4926857118d4855db1c92025-01-18T05:30:52ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742024-08-01208e101243910.1371/journal.ppat.1012439NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.Harikrishnan BalachandranKyle KrollKaren TerryCordelia ManickamRhianna JonesGriffin WoolleyTammy HayesAmanda J MartinotAnkur SharmaMark LewisStephanie JostR Keith ReevesNatural killer (NK) cells play a critical role in virus control. However, it has remained largely unclear whether NK cell mobilization in SARS-CoV-2 infections is beneficial or pathologic. To address this deficit, we employed a validated experimental NK cell depletion non-human primate (NHP) model with SARS-CoV-2 Delta variant B.1.617.2 challenge. Viral loads (VL), NK cell numbers, activation, proliferation, and functional measures were evaluated in blood and tissues. In non-depleted (control) animals, infection rapidly induced NK cell expansion, activation, and increased tissue trafficking associated with VL. Strikingly, we report that experimental NK cell depletion leads to higher VL, longer duration of viral shedding, significantly increased levels of pro-inflammatory cytokines in the lungs, and overt lung damage. Overall, we find the first significant and conclusive evidence for NK cell-mediated control of SARS-CoV-2 virus replication and disease pathology. These data indicate that adjunct therapies for infection could largely benefit from NK cell-targeted approaches.https://doi.org/10.1371/journal.ppat.1012439
spellingShingle Harikrishnan Balachandran
Kyle Kroll
Karen Terry
Cordelia Manickam
Rhianna Jones
Griffin Woolley
Tammy Hayes
Amanda J Martinot
Ankur Sharma
Mark Lewis
Stephanie Jost
R Keith Reeves
NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
PLoS Pathogens
title NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
title_full NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
title_fullStr NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
title_full_unstemmed NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
title_short NK cells modulate in vivo control of SARS-CoV-2 replication and suppression of lung damage.
title_sort nk cells modulate in vivo control of sars cov 2 replication and suppression of lung damage
url https://doi.org/10.1371/journal.ppat.1012439
work_keys_str_mv AT harikrishnanbalachandran nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT kylekroll nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT karenterry nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT cordeliamanickam nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT rhiannajones nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT griffinwoolley nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT tammyhayes nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT amandajmartinot nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT ankursharma nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT marklewis nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT stephaniejost nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage
AT rkeithreeves nkcellsmodulateinvivocontrolofsarscov2replicationandsuppressionoflungdamage